• Home
  • About Us
  • Fluoroquinolones
    • FDA Warnings
    • EMA Warnings
    • Toxicity Warnings
    • Drug List
    • Chemical Composition
    • Library A-M
    • Library N-Z
    • Most Important Studies
  • Our Research
    • Our Sponsored Research
    • Supporting Studies
  • Find Help
  • Contact Us
  • Disclaimer
  • More
    • Home
    • About Us
    • Fluoroquinolones
      • FDA Warnings
      • EMA Warnings
      • Toxicity Warnings
      • Drug List
      • Chemical Composition
      • Library A-M
      • Library N-Z
      • Most Important Studies
    • Our Research
      • Our Sponsored Research
      • Supporting Studies
    • Find Help
    • Contact Us
    • Disclaimer
  • Home
  • About Us
  • Fluoroquinolones
    • FDA Warnings
    • EMA Warnings
    • Toxicity Warnings
    • Drug List
    • Chemical Composition
    • Library A-M
    • Library N-Z
    • Most Important Studies
  • Our Research
    • Our Sponsored Research
    • Supporting Studies
  • Find Help
  • Contact Us
  • Disclaimer
Fluoroquinolone Toxicity Study, NFP

European Medicines Agency (EMA) Warnings

  

European Medicines Agency’s (EMA) Fluoroquinolone Press Release 2019:

https://www.ema.europa.eu/en/documents/referral/quinolone-Fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf


European Medicines Agency’s (EMA) Fluoroquinolone Public Hearing 2018:

https://www.ema.europa.eu/en/documents/other/public-hearing-quinolone-Fluoroquinolone-written-interventions_en.pdf


Summary -

https://www.ema.europa.eu/en/documents/report/summary-ema-public-hearing-quinolone-fluoroquinolone-antibiotics_en.pdf 


 Main points raised -
• Symptoms were life-changing and wide ranging.
• Patients were not given information about risks.
• Healthcare professionals were generally unaware of the range and severity of possible symptoms,
with the exception of Achilles tendon disorders 


13 patient testimonies before the EMA 2018 starting at minute 14:15

https://www.youtube.com/watch?v=1vao8o5NGUc



Pharmacovigilance Risk Assessment Committee (PRAC) Assessment Report 2018:

https://www.ema.europa.eu/en/documents/referral/quinolone-Fluoroquinolone-article-31-referral-assessment-report_en.pdf

 The following mechanisms may be supportive of a causal relationship between (fluoro) quinolones and tendon disorders: 

Tendon disorders

  • Oxidative stress (ROS overproduction)
  • Mitochondrial damage
  • Inhibition of tenocytes proliferation 
  • Inhibition of tenocytes migration
  • Enhanced expression of matrixmetalloproteinases (MMPs)
  • Induced apoptosis
  • Chelation of metal ions by quinolones
  • Ischemia and contribution of poor vascularization in tendon tissue

Neurotoxicity

Neuropathies

Phototoxicity

Vasculitis



******************************************************************************************************


Interactive Drug Analysis Profile (ADR's):


Avelox:  https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_001005786432.zip&agency=MHRA  


Levofloxacin:  https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000197682791.zip&agency=MHRA


Ciprofloxacin:  https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=.%2FUK_EXTERNAL%2FNONCOMBINED%2FUK_NON_000956188993.zip&agency=MHRA&fbclid=IwAR1UdRBrO5wPLEM-Jaaohi2Ycjh2xRm08RXAQeHYiLnTdTj8c5SommRxMAg

Connect With Us

Help Our Cause

Your support and contributions will help fund our latest research study currently  in process. 

Pay with PayPal or a debit/credit card
  • About Us
  • FDA Warnings
  • EMA Warnings
  • Toxicity Warnings
  • Drug List
  • Chemical Composition
  • Library A-M
  • Library N-Z
  • Most Important Studies
  • Our Sponsored Research
  • Supporting Studies
  • Find Help
  • Contact Us

Copyright © 2020  - All Rights Reserved.

Powered by GoDaddy Website Builder